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1. Introduction 
Low Mr fragments (8000-20 000) derived by kal- 
likrein digestion of human HMr (120 000) kininogen 
have long been sought for [l-5]. In [2] purified I-I& 
kininogen was incubated with human plasma kalhkrein 
producing an 8000 Mr fragment isolated on Sephadex 
G-50. A glycopeptide (M, 4600) and a histidine-rich 
peptide (M, 8000) obtained with bovine plasma kal- 
likrein from purified bovine I-LUr kininogen have been 
clearly established by sequence analyses [6]. 
We have developed aradioimmunoassay for the 
detection of molecular forms of human plasma kinin- 
ogen separated by SDS-PAGE [7]. It could be shown 
that I&U, and LMr (58 000) kininogens share antigenic 
determinants in the heavy chain. Here, we show that 
a LiVr fragment (-8000) with the similar antigenic 
response is found in human plasma in the absence of 
activated kallikrein. After isolation 2 or 3 antigenic 
fragments (M, 8000-l 1 000) were identified. Further 
these results exclude that the fragments are derivatives 
of the KM, kininogen light chain but strongly suggest 
that they may be parts of the heavy chain. As shown 
in [7,8] the antigenic determinants of a kininogen iso- 
lated from Cohn’s fraction IV R-antigen) appear to 
be resistant to activated intrinsic proteinases. Attempts 
have been made to correlate the formation of the I&f, 
antigenic fragments with the intrinsic spontaneously 
or glass-activated kallikrein as measured on the syn- 
thetic substrate H-D-Pro-Phe-Arg-pNA [9]. 
Abbreviations: DFP, diisopropylfluorophosphate; EACA, 
e-aminocaproic acid; EDTA, ethylenediamine tetraacetic acid; 
HM,, high molecular mass kininogen; LA&, low molecular 
mass kininogen; PBR, hexadimethrine bromide; PMSF, phen- 
ylmethane sulfonyl fluoride; RIA, radioimmunoassay; SDS- 
PAGE, sodium dodecyl sulphate polyacrylamide gel electro- 
phoresis 
2. Materials and methods 
2 .I. Plasma materials 
Single donor plasma was taken i to polypropylene 
tubes containing 1. ml ACD anticoagulant solution 
(citric acid, trisodium citrate, dextrose)/9 ml blood 
and collected after centrifugation. 
Plasma from 2 donors and human blood bank 
plasma (anticoagulant citrate, dextrose, phosphate, 
CPD) were obtained from the Finnish Red Cross Blood 
Transfusion Service (by courtesy of Dr G. Myllyla). 
2.2. Isolation of fragments 
QAE-Sephadex A-50 was equilibrated at ionic 
strength = 0.12 with 0.02 M Na-phosphate buffer 
(pH 8.0), 0.1 M EACA, 0.03 M EDTA, 3 mM PMSF 
(Sigma) or 0.1 M Tris-HCl (PH 8.0), 0.03 M EDTA, 
3 mM PMSF. Normal human blood bank plasma 
(400 ml) was diluted 1: 1.6 with buffer [2,7], poured 
into the siliconated QAE column (4.4 X 20 cm), pre- 
washed with 0.04% PBR and operated at 200 ml/h, 
4°C. After collecting the effluent washing was per- 
formed with 2.5 column vol. buffer. The stepwise salt 
elution was started by addition of NaCl to the buffer 
to ionic strength = 0.20. The fragment fraction was col- 
lected between ionic strength = 0.16-0.20 (av.6 runs, 
table 1) measured in each eluted fraction using the 
Philips conductivity bridge PR 9500. Repeated wash- 
ing was performed with 1000 ml buffer ionic strength 
= 020. I-IiVr kininogen was collected after changing to 
ionic strength = 0.35 buffer. 
After dialysis (until ionic strength = 0.05) the frag- 
ment fraction pool was poured into a CM-Sephadex 
A-50~column (4.1. X 10 cm, 100 ml/h), using 0.02 M 
Na-phosphate (pH 6.0) containing 0.05 M NaCl and 
0.0 1 M EDTA and elution with a stepwise salt gradient 
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0.3-0.5 M NaCl [2]. The fragment was eluted between 
ionic strength = 0.32-0.46. 
Antigenic fragment was also isolated from a recycled 
QAE-fragment fraction pool using an immunoadsorbent 
column (0.9 X 30 cm) prepared with antiserum raised 
in rabbits against the kininogen Q-antigen as in [8]. 
‘fhe binding capacity of the immunosorbent was 
5.3 mg k-antigen. 
2 3. SDS-PAGE 
Analytical runs employed 5- 10 111 plasma nd 
5- 10 pg lyophilized immunoreactive fragment sam- 
ples on 8% or 12% polyacrylamide (BDH Chemicals) 
slab gel [lo] (20-25 mA at room temperature for 
10 h). Identification of immunoreactive fragment was 
performed by slicing the gel over the entire rumring 
distance with a circular gel punch (diam. 3.7 mm) 
fitting the punched holes used in Quchterlony double 
diffusion analysis [111. Control runs with protein 
markers were run in parallel. Serva blue R was used 
for staining. 
Preparative runs were performed on 12% slab gels 
(150 X 150 X 2 mm) with 13 mg total protein. The 
gels were run at 40 mA for 10 h, after which the 
immunoreactive fragment was located by Quchterlony 
double diffusion analysis as described. Antigenic frag 
ment was located and recovered between M, 8000- 
11 000 from the sliced (1 X 1 X 2 mm) gel pieces by 
elution with 10 ml distilled water with shaking for 
20 h (22°C). SDS and salt were removed on Sephadex 
G-25. 
2.4. Kallikrein 
Glass contact activation of plasma kallikrein was 
performed as in [7]. Kalhkrein activity was determined 
using 0.09 mM synthetic substrate H-D-Pro-Phe- 
Arg-pNA (s-2302, Kabi). One amidase unit is equal 
to 1 pmol p-nitroaniline released/mm [ 121. 
2.5 . Antisera 
Monospecific antisera against immurrolog.ic~Y 
pure L&f,-kininogen f 131 and the kininogen k-antigen 
were raised in rabbits [8]. The titers were 0.3 mg/ml 
and 1 .O mg/ml, respectively [14]. 
2.6. Quantitation of antigenic fmgments 
Single radial immunodiffusion [ 151 was used for 
quantitation of LMr kininogen.fragments after ion- 
exchange chromatography. 
2.7. Radioimmunoassay 
Kininogen I$+rain (10 pg) was radioiodinated to 
spec. act. 25 @/pg. Radioimmunoassay was performed 
using the monospecific antikininogen I-&hain serum 
as in [7]. 
3. Results 
The results obtained by RIA with eluates of gel 
slices after SDS-PAGE of 10 4 single donor plasma 
are shown in fig.1. The immunoreactive fragment is 
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Fig.1. (a) Immunoreactive fragment, Mr 8700, from 10 gl 
single donor plasma together with LMr kininogen, Mr 5 7 000, 
assayed by radioimmunoassay (ng BKG) of 50 ~1 eluates after 
separation on 12% SDS-PAGE; (b) the same analysis using 
8% SDS-PAGE and 150 ~1 eluates howing HM, 94 000, 
L&f, 55 000 and fragment moving in the front. 
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observed at Mr 8700 together with LMr kininogen 
57 000 (fIg.la). HMr kininogen could not be detected 
with this amount of eluate but appeared at MI 94 000 
with 3 times more eluate from an 8% SDS-PAGE. 
Fig.1 b shows the fragment separately in the diagram 
due to the high content and uncertainty of M, since it 
was found close to the marker on the gel. In a similar 
run with two donors plasma 3 different immunoreac- 
tive kininogens were located (tig.2a). The unusually 
high content of immunoreactive kininogen in this 
plasma (see table 1, I) acounds for the appearance of
Wrkininogen already with 50 ~1 eluate. These results 
illustrate only qualitatively the immunoreactive kinin- 
ogen components. It is unknown to what extent SDS 
may influence the antigenic reaction. It is therefore 
not possible to compare quantitatively at this moment 
the antigenic response of the fragment, which appears 
to be too high compared with the other components. 
Furthermore, as seen in fig2b, an MI 61 000 compo- 
nent was also found in the QAE-fragment fraction 
pool. 
Fig.3 shows the isolation of the fragment fraction 
by step-wise salt elution after QAE-chromatography, 
clearly separated from the LMr kininogen fractions in 
the effluent, in which abundantly free kallikrein could 
be measured espite the use of inhibitor (PMSF), and 
from the HMr kininogen eluted at ionic strength = 0.35. 
Recycling on QAE-Sephadex of the fragment pool 
obtained in the first run with 400 ml CPD plasma 
submitted to glass contact activation (table 1, III) 
yielded a homogeneous fraction illustrated in fig.3 
(inset). 
Table 1 summarizes the separation of immuno- 
reactive kininogen by QAE-chromatography in 3 frac- 
A 
280 ml EKG 
I mglml ,.o*-a.20 
M NaCl - 
1.2 0.75 
.-. 
0.6 0.50 
0.25 / :’ 
I Dk , o,2y~~~q 
1500 elution v&me ml 2500 3100 
Fig.2. (a) Immunoreactive fragment, M, 8100, from 10 ~1 
two donors plasma together with HMr 82 000, LMr 61000 
Fig.3.QAE-Sephadex A-50 chromatography of 400 ml human 
plasma collecting the fragment fraction by stepwise elution 
assayed by radioimmunoassay (ng BKG) of 50 ~1 eluates after ionic strength = 0.2, protein profne,tl,,, (---); for kinin- 
after separation on 12% SDS-PAGE; (b) a similar run of ogen content see table 1,L The inset figure shows the recycling 
recycled QAE-fragment preparation (7 rg immunoreactive on QAE-Sephadex A-50 of the fragment fraction pool in a 
kininogen) showing the fragment at Mr 8800. The respective linear salt gradient between ionic strength = 0.08-0.24 (--.). 
stained gels run in parallel are shown together with molecular Immunoreactive kininogen (BKG) assayed by single radial 
markersMr 78 000,68 000,43 000,12 000 (from left to right). immunoditfusion (o---o). 
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Table 1 
Immunoreactive kininogen in LMr, fragment (M, 8000-l 1 000) and HMr fraction pools separated by 
stepwise salt elution after QAE-chromatography compared with kaBikrein activity on H-D-Pro-Phe- 
Arg-pNA in the starting plasma 
Prep. Kallikrein (mg/ml) Immunoreactive kininogen (mg) Kininogen mg/ml plasma 
Spontaneous Glass-contact LM, Fragment HMr Total starting 
activated recovered plasma 
I 0 - 128.1 24.2 15.1 0.372 0.358 
II 3.9-13.4 - 101.4 5.1 15.7 0.301 0.306 
III 0 4.2-5.8 80.5 21.8 9.1 0.279 0.269 
IV f 1.4-9.9 82.4 19.3 2.9 0.262 0.283 
v + 7.2 73.8 19.4 10.9 0.260 0.272 
VI f 4.9 86.2 9.3 11.8 0.268 0.286 
U/ml range given for increase after dilution of the plasma 
Immunoreactive kininogen determined as in [ 81 by single radial immunodiffusion using monospecific 
anti-kininogen serum against he antigen isolated from Cohn’s fraction IV (HC-chain) 
I, 450 ml starting plasma from 2 donors; V, VI, chromatographed without addition of inhibitors 
tion pools containing antigenic fragment, LM, and 
HMr kininogen. Autoactivated kallikrein was found in 
one of the plasma samples (table 1, II) despite protec- 
tion against contact activation. The activities obtained 
after glass-contact were between 1.4-9.9 U/ml. 
Purification with immunoadsorbent was performed 
with the dialysed and lyophilised preparation obtained 
from a recycled QAE-fraction pool (fig.3, inset) con- 
taining 1.8 mg immunoreactive kininogen/69 mg pro- 
tein. All kininogen was retained by the column. After 
elution with 8 M urea 0.67 mg kininogen (37%) was 
recovered. This preparation was used for immuniza- 
tion as in [8]. As shown in figAa the anti-fragment 
Fig.4. Characterization by double immunodiffusion of (a) 
the anti-HC-chain serum and (b) the anti-fragment serum 
showing antigenic identity of LMr (5 fig), HMr (5 ccg) and the 
HC-chain (2.5 9s). In center wells 30 ~1 anti-HC-serum and 
anti-fragment serum, respectively. 
serum responds antigenically to the LM,, Hil4r and 
k-antigens. This shows that the fragment shares at 
least one antigenic determinant with these molecules 
as sustained in figAb. This is further sustained in fig.5 
showing identical RIA inhibition curves produced by 
the QAE-fragment fraction pool and fragment further 
purified from the QAE-pool by SDS-PAGE in com- 
parison with the q-antigen, HM, and LMr kininogens. 
BIB, 
1.0‘ 
0.5 - 
Fig.5 Radioimmunoassay inhibition curves showing antigenic 
identity of fragment in the QAE-fraction pool (9) and frag- 
ment, Mr 8000-l 1000, isolated from the QAE-pool by 
SDS-PAGE (*) with HMr kininogen (o), I.&f, kininogen (0) 
and the HC-antigen (0). B/E, is the ratio of radioactivity 
(“‘I-labeled HC-antigen) bound to anti-HC-serum in the 
presence and absence of inhibitor. 
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Fig.6. CM-Sephadex A-50 chromatography using stepwise 
elution of the fragment fraction pool from QAE-chromatog- 
raphy. Immunoreactive fragment(s) (BKG) assayed by single 
radial immunodiifusion (o---o) was eluted between ionic 
strength = 0.32-0.46 (.-.); the content of kininogen deter- 
mined in the pools collected as indicated; protein profde, 
A,,, (-). 
The QAE-fragment fraction pool was submitted to
CM-Sephadex chromatography shown in fig.6. Three 
immunoreactive fractions were obtained containing 
1.5 mg, 2.2 mg and 2.1 mg (total 5 .S) kininogen, 
respectively. 
4. Discussion 
There are two different approaches in isolating 
plasma kininogens: 
(1) After blocking proteinases with DFP, which yields 
only Hil4rllO 000-120 000 [ 1,2]; 
(2) Using blocking with other inhibitors of activated 
kallikrein produced uring preparative procedures. 
We have applied the latter method allowing activation 
of F XII by glass contact during preparation. By this 
method, allowing binding of activated proteinases to
natural inhibitors in plasma nd to a I&f, kallikrein 
inhibitor (PMSF) at least 3 HM, molecular forms 
between 105 000-85 000 were earlier detected by 
RIA after elution from SDS-PAGE [7]. The present 
finding that a fragment with Mr - 8000 also is found 
in the fresh human plasma lacking kallikrein activity 
is particularly intriguing (fig.l,2) and may suggest 
that this fragment is a degradation product formed by 
other intrinsically activated proteinases connected with 
coagulation and fibrinolysis. The possibility that frag- 
ment may be formed from HM, kininogen is so far 
unclear although some results eem to indicate this 
(table 1, IV). The presence of fragment in the fresh 
plasma may further suggest immunological cross reac- 
tivity with some other plasma protein. As shown in 
fig.6 several antigenically similar LM, fragments were 
found. It is of interest o note (flg.4,5) that the frag- 
ment responds immunologically to the same deter- 
minant as found in Lilf,, HM, and the e-antigen 
located in the heavy chain [7,8]. 
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